Rankings
▼
Calendar
OCGN Q4 2017 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$710M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$7M
EPS (Diluted)
$-16.99
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$340,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$22M
Stockholders' Equity
-$11M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$6M
-$8M
+23.7%
Net Income
-$7M
$9M
-175.0%
← FY 2017
All Quarters
Q1 2018 →